These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 37588217)

  • 1. Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine.
    Khoshandam M; Soltaninejad H; Mousazadeh M; Hamidieh AA; Hosseinkhani S
    Genes Dis; 2024 Jan; 11(1):268-282. PubMed ID: 37588217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy.
    Guo N; Liu JB; Li W; Ma YS; Fu D
    J Adv Res; 2022 Sep; 40():135-152. PubMed ID: 36100322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing.
    Sinclair F; Begum AA; Dai CC; Toth I; Moyle PM
    Drug Deliv Transl Res; 2023 May; 13(5):1500-1519. PubMed ID: 36988873
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Lau CH; Suh Y
    F1000Res; 2017; 6():2153. PubMed ID: 29333255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications.
    Cheng H; Zhang F; Ding Y
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of CRISPR/Cas9 for therapeutic genome editing.
    Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
    J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Self-Deleting AAV-CRISPR System for
    Li A; Lee CM; Hurley AE; Jarrett KE; De Giorgi M; Lu W; Balderrama KS; Doerfler AM; Deshmukh H; Ray A; Bao G; Lagor WR
    Mol Ther Methods Clin Dev; 2019 Mar; 12():111-122. PubMed ID: 30619914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivering the CRISPR/Cas9 system for engineering gene therapies: Recent cargo and delivery approaches for clinical translation.
    Foley RA; Sims RA; Duggan EC; Olmedo JK; Ma R; Jonas SJ
    Front Bioeng Biotechnol; 2022; 10():973326. PubMed ID: 36225598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-clinical non-viral vectors exploited for
    Rouatbi N; McGlynn T; Al-Jamal KT
    Biomater Sci; 2022 Jun; 10(13):3410-3432. PubMed ID: 35604372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Genome Editing and In Vivo Delivery.
    Ramirez-Phillips AC; Liu D
    AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics.
    Liu W; Li L; Jiang J; Wu M; Lin P
    Precis Clin Med; 2021 Sep; 4(3):179-191. PubMed ID: 34541453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral Vectors for the
    Asmamaw Mengstie M
    Front Bioeng Biotechnol; 2022; 10():895713. PubMed ID: 35646852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-target effects in CRISPR/Cas9 gene editing.
    Guo C; Ma X; Gao F; Guo Y
    Front Bioeng Biotechnol; 2023; 11():1143157. PubMed ID: 36970624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid nanoparticles: The game-changer in CRISPR-Cas9 genome editing.
    Mohammadian Farsani A; Mokhtari N; Nooraei S; Bahrulolum H; Akbari A; Farsani ZM; Khatami S; Ebadi MS; Ahmadian G
    Heliyon; 2024 Jan; 10(2):e24606. PubMed ID: 38288017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer.
    Wang SW; Gao C; Zheng YM; Yi L; Lu JC; Huang XY; Cai JB; Zhang PF; Cui YH; Ke AW
    Mol Cancer; 2022 Feb; 21(1):57. PubMed ID: 35189910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of genome-editing biomacromolecules for treatment of lung genetic disorders.
    Wan T; Ping Y
    Adv Drug Deliv Rev; 2021 Jan; 168():196-216. PubMed ID: 32416111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current updates of CRISPR/Cas9-mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management.
    Allemailem KS; Alsahli MA; Almatroudi A; Alrumaihi F; Alkhaleefah FK; Rahmani AH; Khan AA
    Cancer Commun (Lond); 2022 Dec; 42(12):1257-1287. PubMed ID: 36209487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.